We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.3%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$38.5B
AUM Growth
+$4.48B
(+13%)
Cap. Flow
+$4.55B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
2,364
New
149
Increased
1,180
Reduced
895
Closed
134
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$275M |
| 2 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$221M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$193M |
| 4 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$188M |
| 5 |
First Trust Consumer Discretionary AlphaDEX Fund
FXD
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$230M |
| 2 |
Spectrum Brands
SPB
|
+$81.6M |
| 3 |
Chevron
CVX
|
+$79.8M |
| 4 |
Pfizer
PFE
|
+$66.7M |
| 5 |
K
Kellanova
K
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.09% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Technology | 9.81% |
| 4 | Consumer Staples | 7.93% |
| 5 | Communication Services | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Equifax
EFX
$20.3B
| $20.4M | 0.05% |
209,718
+132,613
| +172% | +$12.9M |
|
|
TECD
427
DELISTED
Tech Data Corp
TECD
| $20.3M | 0.05% |
353,472
+101,914
| +41% | +$6.14M |
|
428
Dentsply Sirona
XRAY
$2.59B
| $20.3M | 0.05% |
393,496
+71,810
| +22% | +$3.72M |
|
429
Robert Half
RHI
$3.61B
| $20.2M | 0.05% |
363,970
+7,662
| +2% | +$438K |
|
430
Stryker
SYK
$127B
| $20.2M | 0.05% |
211,092
-336,221
| -61% | -$31.9M |
|
431
Republic Services
RSG
$66.7B
| $20.1M | 0.05% |
514,109
-181,060
| -26% | -$7.28M |
|
432
Western Union
WU
$2.57B
| $20.1M | 0.05% |
989,648
+619,788
| +168% | +$13.2M |
|
433
BorgWarner
BWA
$13.2B
| $20.1M | 0.05% |
401,081
+139,996
| +54% | +$7.47M |
|
434
Paychex
PAYX
$40.4B
| $20.1M | 0.05% |
427,932
-20,450
| -5% | -$1,000K |
|
435
Deere & Co
DE
$170B
| $20M | 0.05% |
206,149
-50,460
| -20% | -$4.59M |
|
436
Emerson Electric
EMR
$82.9B
| $20M | 0.05% |
360,701
+110,875
| +44% | +$6.51M |
|
437
Pultegroup
PHM
$24.5B
| $19.9M | 0.05% |
988,562
+59,209
| +6% | +$1.2M |
|
438
Zions Bancorporation
ZION
$10.1B
| $19.9M | 0.05% |
626,855
+444,008
| +243% | +$13.1M |
|
439
Eversource Energy
ES
$28.2B
| $19.8M | 0.05% |
436,832
+73,107
| +20% | +$3.54M |
|
440
Estee Lauder
EL
$29B
| $19.8M | 0.05% |
228,603
+189,260
| +481% | +$16.3M |
|
441
Humana
HUM
$46.7B
| $19.8M | 0.05% |
103,354
-9,544
| -8% | -$1.77M |
|
442
Alliant Energy
LNT
$19.4B
| $19.7M | 0.05% |
683,684
+235,738
| +53% | +$7.15M |
|
443
Zimmer Biomet
ZBH
$17.7B
| $19.7M | 0.05% |
185,796
+18,221
| +11% | +$2.02M |
|
|
CTXS
444
DELISTED
Citrix Systems Inc
CTXS
| $19.7M | 0.05% |
351,956
+30,814
| +10% | +$1.64M |
|
445
MDU Resources
MDU
$4.44B
| $19.6M | 0.05% |
2,645,173
+63,631
| +2% | +$511K |
|
446
Roper Technologies
ROP
$36.3B
| $19.6M | 0.05% |
113,491
+62,294
| +122% | +$10.8M |
|
|
RICE
447
DELISTED
Rice Energy Inc.
RICE
| $19.5M | 0.05% |
937,289
+364,384
| +64% | +$8.28M |
|
448
Open Text
OTEX
$5.43B
| $19.5M | 0.05% |
963,370
+329,080
| +52% | +$7.93M |
|
|
DNR
449
DELISTED
Denbury Resources, Inc.
DNR
| $19.5M | 0.05% |
3,064,827
-1,073,757
| -26% | -$8.19M |
|
450
Vanguard Real Estate ETF
VNQ
$39.9B
| $19.4M | 0.05% |
260,390
+261
| +0.1% | +$20.9K |
|
Similar funds
DAM
First Trust Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, First Trust Advisors held 2,364 positions worth $38.5B, up 13% from $34B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
First Trust Advisors deployed $4.55B of net new capital in Q2 2015, opening 149 new positions and adding to 1,180 existing holdings. Its largest new stake was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Chevron, an estimated $79.8M trimmed.
- First Trust Advisors's largest Q2 2015 buy was Agios Pharmaceuticals: 1,079,286 shares worth $120M.
- First Trust Advisors added most to First Trust NYSE Arca Biotechnology Index Fund in Q2 2015, an estimated $275M increase.
- First Trust Advisors's biggest Q2 2015 reduction was Chevron, cutting an estimated $79.8M.
- First Trust Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $230M.
- First Trust Advisors's ten largest holdings make up 14% of its $38.5B portfolio in Q2 2015.
- First Trust Advisors opened 149 new positions and closed 134 in Q2 2015.
- First Trust Advisors's portfolio value rose 13% quarter-over-quarter to $38.5B.
Based on First Trust Advisors's 13F filing for Q2 2015, filed 4 Aug 2015.